Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer(2022 edition)
摘要
Treatment of breast cancer with low expression of human epidermal growth factor receptor 2(HER2;HER2-low)has drawn much attention in recent years.With the proven therapeutic effect of trastuzumab deruxtecan(T-DXd)in patients with HER2-low(immunohistochemistry[IHC]1+,or IHC2+/in situ hybridization[ISH]-)breast cancer,HER2-low may become a new subtype of targeted therapy for breast cancer.The expert committee formulated this consensus based on the current clinical studies and clinical medication experience.The current consensus is the collaborative work of an interdisciplinary working group,including experts in the fields of pathology and oncology.The purpose of this consensus was to guide the clinical diagnosis and treatment of HER2-low breast cancer,thereby prolonging the overall survival of patients.
二级参考文献11
-
1张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量：29
-
2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量：164
-
3乳腺癌HER2检测指南（2009版）[J].中华病理学杂志,2009,38(12):836-840. 被引量：192
-
4应建明,郭蕾,刘秀云,邱田,吕宁.全自动银增强原位杂交检测乳腺癌患者人表皮生长因子受体2基因状态[J].中华医学杂志,2010,90(24):1674-1677. 被引量：11
-
5杨壹羚,范宇,郎荣刚,谷峰,付丽.乳腺癌HER2基因遗传异质性与其临床病理特征的相关性研究[J].中华医学遗传学杂志,2010,27(5):540-545. 被引量：9
-
6倪韵碧,杨雯娟,步宏,郑鸿.乳腺癌HER2检测的必要性[J].中华病理学杂志,2011,40(2):76-78. 被引量：10
-
7杨飞,杨文涛,步宏.乳腺癌HER2检测中的新问题[J].中华病理学杂志,2012,41(5):289-292. 被引量：12
-
8许燕,杨文涛,杨飞,陆永明,蔡旭,周晓燕.双色银染原位杂交与荧光原位杂交在乳腺癌HER2基因状态评估中的比较[J].中华病理学杂志,2014,43(4):226-230. 被引量：8
-
9乳腺癌HER2检测指南（2014版）[J].中华病理学杂志,2014,43(4):262-267. 被引量：295
-
10杨雯娟,魏兵,陈敏,步宏.乳腺浸润性微乳头状癌HER2免疫组织化学染色结果的判读方法探讨[J].中华病理学杂志,2015,44(1):48-52. 被引量：10
共引文献294
-
1曹春莉,石丽楠,童瑾,李文肖,许娅,李军.基于超声特征联合免疫组化列线图模型预测老年乳腺癌腋窝淋巴结转移[J].中国老年学杂志,2024,44(9):2070-2074.
-
2刘晔,任雷,顾慧,陈吉,李丽,鲍书友,蒋红妹,李葵芳.乳腺大汗腺癌及癌前病变9例临床病理分析[J].诊断病理学杂志,2023,30(9):897-898.
-
3张宴,凌月仙,王冬冬,赵佩瑶,谢楠玉,郜红艺.男性乳腺疾病62例临床病理分析[J].诊断病理学杂志,2022,29(9):789-792. 被引量：1
-
4李晓慧,陈春建.大分割放疗对糖尿病患者乳腺癌根治术后肺功能及并发症的影响[J].中国医学工程,2020,0(2):91-93.
-
5杨俊荣,徐文鑫,穆红,高福平.Ki-67和TOPOⅡα在女性乳腺浸润性导管癌中的表达及临床意义[J].热带医学杂志,2023,23(3):392-395. 被引量：1
-
6陶志远,杨婷,倪云哲,史春颖.肿块周围低密度晕环对乳腺癌的诊断价值及临床意义[J].哈尔滨医科大学学报,2023,57(1):56-60.
-
7褚明亮,胡建军,侯净,张著学.乳腺癌组织学特征与其FISH检测中酶消化时间的相关研究[J].基因组学与应用生物学,2021,40(11):3818-3823.
-
8岳瑞雪,孔令欣,郝鑫,杨进强,韩猛,崔国忠,王建军,张志生,孔凡庭,张维,何文博,李现桥,周新平,徐东宏,胡崇珠.乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J].中华临床医师杂志（电子版）,2023,17(7):765-770.
-
9刘倩,向泓雨,刘荫华.HER2阳性早期乳腺癌新辅助治疗概述[J].中华临床医师杂志（电子版）,2021,15(10):726-730.
-
10饶维智,黄湘平.建立新体制 推进企业化[J].中国地质矿产经济,2000,13(3):6-8.
-
1Francisco J.Esteva,Shabnam Jaffer.HER2-low metastatic breast cancer: molecular insights and therapeutic strategies[J].Journal of Cancer Metastasis and Treatment,2023,9(1):541-547.
-
2Jiayu Wang,Yunjiang Liu,Qingyuan Zhang,Wei Li,Jifeng Feng,XiaojiaWang,Jianmin Fang,Yiqun Han,Binghe Xu.Disitamab vedotin,a HER2-directed antibody-drug conjugate,in patients with HER2-overexpression and HER2-low advanced breast cancer:a phase I/Ib study[J].Cancer Communications,2024,44(7):833-851.
-
3郑宇晨,和水祥.曲妥珠单抗治疗人表皮生长因子受体2阳性晚期胃癌的研究进展[J].西安交通大学学报（医学版）,2024,45(6):879-884.
-
4曾铖,张剑.抗体药物偶联物在三阴性乳腺癌中的应用[J].中华乳腺病杂志（电子版）,2024,18(3):140-145.
-
5吴向东,徐东宏.人表皮生长因子受体2低表达乳腺癌的研究进展[J].肿瘤研究与临床,2024,36(8):630-633.
-
6温鑫鑫,李南林.抗体药物偶联类药物在乳腺癌脑转移治疗中的研究进展[J].中华神经外科疾病研究杂志,2024,18(5):72-75.
-
7Huizi Lei,Yun Ling,Pei Yuan,Xieqiao Yan,Lin Wang,Yanxia Shi,Xin Yao,Hong Luo,Benkang Shi,Jiyan Liu,Zhisong He,Guohua Yu,Weiqing Han,Changlu Hu,Zhihong Chi,Chuanliang Cui,Lu Si,Jianmin Fang,Jun Guo,Xinan Sheng,Aiping Zhou,Jianming Ying.Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer[J].Journal of the National Cancer Center,2023,3(2):121-128.
-
8Inflammatory Bowel Disease Group,Chinese Society of Gastroenterology,Chinese Medical Association,Inflammatory Bowel Disease Quality Control Center of China,Kaichun Wu,Minhu Chen,Jiaming Qian.2023 Chinese national clinical practice guideline on diagnosis and management of ulcerative colitis[J].Chinese Medical Journal,2024,137(14):1642-1646.
-
9叶松青,王瑞娟,曾焕虹.抗体药物偶联物治疗HER-2阳性乳腺癌[J].中华乳腺病杂志（电子版）,2024,18(3):192-192.
-
10浙江省医院协会药事管理专业委员会,浙江省医院药事管理质控中心,浙江省抗癌协会肿瘤临床药学专业委员会,浙江省药学会抗肿瘤药物专业委员会,卢晓阳,黄萍,谢升阳,蒋正立,叶子奇,王直滔,郑小卫,郑小春.靶向淋巴细胞抗体超说明书用药实践指引[J].中国现代应用药学,2024,41(20):2868-2878.
